Rotarix licensed in Singapore

Singapore has licensed GSK's new vaccine against rotavirus gastroenteritis among children under 5 years old. The vaccine was tested in 11 polyclinics and three hospitals in Singapore. Rotavirus gastroenteritis is a viral infection which causes severe diarrhea and kills half a million children worldwide every year.This is apparently the first time that a major pharmaceutical company has conducted large scale vaccine trials licensed the vaccine licensed in Singapore before introducing it in the United States or Europe.